Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma. (Q53851430)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Francesco Passamonti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Paolo Bernasconi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Marzia Varettoni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

13

Cristiana Pascutto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

Mario Lazzarino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

9

Ercole Brusamolino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

10

Maurizio Bonfichi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

12

Sara Burcheri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

6

Silvia Calatroni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Ester Orlandi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Isabella Iacona

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Luciano Isa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mario Regazzi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

4 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

146-153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

Survival after progression in patients with follicular lymphoma: analysis of prognostic factors

30 December 2019

cites work

1 reference

Follicular lymphoma: have we made any progress?

21 January 2018

1 reference

Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen

21 January 2018

1 reference

Immunochemotherapy in indolent non-Hodgkin's lymphoma

21 January 2018

1 reference

Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma

21 January 2018

1 reference

Mitoxantrone–cyclophosphamide–rituximab: an effective and safe combination for indolent NHL

21 January 2018

1 reference

Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study.

21 January 2018

1 reference

A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma

21 January 2018

1 reference

Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.

21 January 2018

1 reference

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival

21 January 2018

1 reference

Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000086769

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16006752%20AND%20SRC:MED&resulttype=core&format=json

release_2goqrngj4bbrfgyzd3w5pjiucu

30 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2goqrngj4bbrfgyzd3w5pjiucu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference